{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T18:13:54Z","timestamp":1788200034486,"version":"build-2803163510"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T00:00:00Z","timestamp":1615852800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20fk0108130"],"award-info":[{"award-number":["JP20fk0108130"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["19HA1001"],"award-info":[{"award-number":["19HA1001"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Medical Microbiology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.ijmm.2021.151496","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T14:51:19Z","timestamp":1616079079000},"page":"151496","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Molecular characterization and antimicrobial resistance of group A streptococcus isolates in streptococcal toxic shock syndrome cases in Japan from 2013 to 2018"],"prefix":"10.1016","volume":"311","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1021-1728","authenticated-orcid":false,"given":"Tadayoshi","family":"Ikebe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rumi","family":"Okuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Kazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyuki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitomi","family":"Ohya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Ohnishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.ijmm.2021.151496_bib0005","first-page":"30523","article-title":"Effectiveness of adjunctive clindamycin in \u03b2-lactam antibiotic-treated patients with invasive \u03b2-haemolytic streptococcal infections in US hospitals: a retrospective multicentre cohort study","volume":"3099","author":"Babiker","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ijmm.2021.151496_bib0010","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1128\/jcm.34.4.953-958.1996","article-title":"Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci","volume":"34","author":"Beall","year":"1996","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ijmm.2021.151496_bib0015","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jama.1993.03500030088038","article-title":"Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. The Working Group on Severe Streptococcal Infections","volume":"269","author":"Breiman","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.ijmm.2021.151496_bib0020","series-title":"M100\u2013S23: Performance Standards for Antimicrobial Susceptibility Testing: Twenty-First Informational Supplement","author":"Clinical and Laboratory Standards Institute","year":"2013"},{"issue":"Suppl. 2","key":"10.1016\/j.ijmm.2021.151496_bib0025","doi-asserted-by":"crossref","first-page":"B216","DOI":"10.1016\/j.vaccine.2012.09.045","article-title":"Group A streptococcal vaccines: paving a path for accelerated development","volume":"31","author":"Dale","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.ijmm.2021.151496_bib0030","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1128\/AAC.43.9.2144","article-title":"Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada","volume":"43","author":"De Azavedo","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijmm.2021.151496_bib0035","doi-asserted-by":"crossref","first-page":"18051","DOI":"10.1038\/s41598-019-54409-2","article-title":"Changes in emm types and superantigen gene content of Streptococcus pyogenes causing invasive infections in Portugal","volume":"9","author":"Fri\u00e3es","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijmm.2021.151496_bib0040","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/978-94-007-0940-9_12","article-title":"The nonideal coiled coil of M protein and its multifarious functions in pathogenesis","volume":"715","author":"Ghosh","year":"2011","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ijmm.2021.151496_bib0045","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1001\/jama.1993.03500030082037","article-title":"The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study","volume":"269","author":"Hoge","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.ijmm.2021.151496_bib0050","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1017\/S0950268803008331","article-title":"Changing prevalent T serotypes and emm types of Streptococcus pyogenes isolates from streptococcal toxic shock-like syndrome (TSLS) patients in Japan","volume":"130","author":"Ikebe","year":"2003","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.ijmm.2021.151496_bib0055","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1017\/S0950268807007984","article-title":"Distribution of emm types among group A streptococcus isolates from patients with severe invasive streptococcal infections in Japan, 2001-2005","volume":"135","author":"Ikebe","year":"2007","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.ijmm.2021.151496_bib0060","doi-asserted-by":"crossref","first-page":"304","DOI":"10.7883\/yoken.63.304","article-title":"Emergence of clindamycin-resistant Streptococcus pyogenes isolates obtained from patients with severe invasive infections in Japan","volume":"63","author":"Ikebe","year":"2010","journal-title":"Jpn. J. Infect. Dis."},{"key":"10.1016\/j.ijmm.2021.151496_bib0065","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1017\/S0950268814001265","article-title":"Increased prevalence of group A streptococcus isolates in streptococcal toxic shock syndrome cases in Japan from 2010 to 2012","volume":"143","author":"Ikebe","year":"2015","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.ijmm.2021.151496_bib0070","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jiac.2017.09.013","article-title":"Molecular characterization and antibiotic resistance of Streptococcus dysgalactiae subspecies equisimilis isolated from patients with streptococcal toxic shock syndrome","volume":"24","author":"Ikebe","year":"2018","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.ijmm.2021.151496_bib0075","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.3389\/fmicb.2017.01052","article-title":"High prevalence of macrolide-resistance and molecular characterization of Streptococcus pyogenes isolates circulating in China from 2009 to 2016","volume":"8","author":"Lu","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ijmm.2021.151496_bib0080","doi-asserted-by":"crossref","first-page":"19988","DOI":"10.2807\/ese.16.41.19988-en","article-title":"Invasive Group A streptococcal disease in Ireland, 2004 to 2010","volume":"16","author":"Martin","year":"2011","journal-title":"Euro Surveill."},{"key":"10.1016\/j.ijmm.2021.151496_bib0085","doi-asserted-by":"crossref","first-page":"E222","DOI":"10.1111\/1469-0691.12134","article-title":"Updated model of group A Streptococcus m proteins based on a comprehensive worldwide study","volume":"19","author":"McMillan","year":"2013","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ijmm.2021.151496_bib0090","doi-asserted-by":"crossref","first-page":"20556","DOI":"10.2807\/1560-7917.ES2013.18.33.20556","article-title":"Increased incidence of invasive group A streptococcal disease in Ireland, 2012 to 2013","volume":"18","author":"Meehan","year":"2013","journal-title":"Euro Surveill."},{"key":"10.1016\/j.ijmm.2021.151496_bib0095","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jinf.2018.05.010","article-title":"Epidemiology of an upsurge of invasive group A streptococcal infections in Ireland, 2012\u20132015","volume":"77","author":"Meehan","year":"2018","journal-title":"J. Infect."},{"key":"10.1016\/j.ijmm.2021.151496_bib0100","doi-asserted-by":"crossref","first-page":"236","DOI":"10.11150\/kansenshogakuzasshi1970.67.236","article-title":"Case report of toxic shock-like syndrome due to group A streptococcal infection","volume":"67","author":"Shimizu","year":"1993","journal-title":"Kansenshogaku Zasshi"},{"key":"10.1016\/j.ijmm.2021.151496_bib0105","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.tim.2010.02.007","article-title":"The streptococcal M protein: a highly versatile molecule","volume":"18","author":"Smeesters","year":"2010","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.ijmm.2021.151496_bib0110","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.2165\/11634180-000000000-00000","article-title":"Invasive group A streptococcal disease: epidemiology, pathogenesis and management","volume":"72","author":"Steer","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.ijmm.2021.151496_bib0115","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/clinids\/14.1.2","article-title":"Invasive group A streptococcus infections","volume":"14","author":"Stevens","year":"1992","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijmm.2021.151496_bib0120","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1128\/AAC.40.11.2562","article-title":"Detection of erythromycin-resistant determinants by PCR","volume":"40","author":"Sutcliffe","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijmm.2021.151496_bib0125","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1099\/jmm.0.001158","article-title":"Changes in epidemiologic characteristics and antimicrobial resistance of Streptococcus pyogenes isolated over 10 years from Japanese children with pharyngotonsillitis","volume":"69","author":"Ubukata","year":"2020","journal-title":"J. Med. Microbiol."}],"container-title":["International Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1438422121000254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1438422121000254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T17:01:25Z","timestamp":1761411685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1438422121000254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S1438422121000254"],"URL":"https:\/\/doi.org\/10.1016\/j.ijmm.2021.151496","relation":{},"ISSN":["1438-4221"],"issn-type":[{"value":"1438-4221","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular characterization and antimicrobial resistance of group A streptococcus isolates in streptococcal toxic shock syndrome cases in Japan from 2013 to 2018","name":"articletitle","label":"Article Title"},{"value":"International Journal of Medical Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijmm.2021.151496","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"151496"}}